Tradestie Institutional Equity Comparison Engine

ARCT vs VNDA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ARCT Overall Edge

ARCT Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) driven by superior Valuation, Momentum & Technical, Options & Structure while VNDA counters with relative strength in Growth & Margin. Fundamentally, ARCT trades at 2.5x Forward P/E with -311.2% operating margin (+6.7% YoY revenue) versus VNDA at 103.1x Forward P/E and -77.6% operating margin (+24.1% YoY). In options structure, ARCT sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro) against VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARCT
ARCT 2.5x vs VNDA 103.1x Fwd P/E
Growth & Margin Winner VNDA
Op Margin -311.2% vs -77.6% ยท YoY +6.7% vs +24.1%
Momentum & Technical Winner ARCT
1Y +8.5% vs -12.6% ยท 52W Pos 24% vs 4%
Options & Structure Winner ARCT
BREAKDOWN (4th %ile IV) vs BREAKDOWN (75th %ile IV)
ARCT NASDAQ
Arcturus Therapeutics Holdings Inc. Common Stock
Pharmaceutical Preparations
$8.43
+0.84% 1D
Market Cap $241.0M
1M Return -18.47%
1Y Return +8.49%
Forward P/E 2.5x
Unified AI Score
57.7 / 100 HOLD
Tech 60.0 Fund 62.0 Flow 72.0 Mom 60.0
VNDA NASDAQ
Vanda Pharmaceuticals Inc.
Pharmaceutical Preparations
$3.79
-4.89% 1D
Market Cap $238.9M
1M Return -5.83%
1Y Return -12.56%
Forward P/E 103.1x
Unified AI Score
49.0 / 100 HOLD
Tech 56.0 Fund 58.0 Flow 65.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ARCT +8.49% VNDA -12.56% Spread: +21.05 pp (ARCT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ARCT Revenue VNDA Revenue ARCT Op. Margin VNDA Op. Margin Margin Edge
FY2018 $20M $190M -138.5% 11.3% VNDA
FY2019 $20M $230M -122.7% 10.0% VNDA
FY2020 $10M $250M -749.8% 11.0% VNDA
FY2021 $10M $270M -1641.3% 15.7% VNDA
FY2022 $210M $250M 5.9% 2.5% ARCT
FY2023 $170M $190M -46.9% -7.2% VNDA
FY2024 $150M $200M -62.8% -20.5% VNDA
FY2025 $80M $220M -93.0% -70.0% VNDA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ARCT (5) vs VNDA (4)
Institutional Metric ARCT VNDA Criterion Row Winner
Market Capitalization Scale $241.0M $238.9M Larger Scale Tie
Trailing P/E Ratio Valuation 2.5x 103.1x Lower Multiple ARCT
Forward P/E Ratio Valuation 2.5x 103.1x Lower Multiple ARCT
Revenue Growth (YoY) Growth +6.7% +24.1% Higher Growth VNDA
Operating Margin (TTM) Profitability -311.2% -77.6% Higher Margin VNDA
Net Profit Margin Profitability -285.9% -119.9% Higher Margin VNDA
Return on Equity (ROE) Capital Efficiency -44.4% -82.5% Higher ROE ARCT
52-Week Range Position Momentum 24% ($6โ€“$18) 4% ($4โ€“$10) Stronger Trend ARCT
Beta / 30D Volatility Risk Regime 2.01ฮฒ ยท 127% Vol 1.25ฮฒ ยท 61% Vol Lower Realized Risk VNDA
Unified Institutional Score Composite Signal 57.7 / 100 (HOLD) 49.0 / 100 (HOLD) Higher Composite ARCT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ARCT vs VNDA Buy Guide
ARCT BREAKDOWN
42d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live ARCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VNDA BREAKDOWN
174d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 75th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live VNDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ARCT nor VNDA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.